KRW 7.96bn in-kind contribution for 100% stake in subsidiary ER
ALUX contributes 85.66% stake in ER VINA to subsidiary ER via in-kind, acquiring 730,131 new shares (KRW 7.96bn), maintaining 100% ownership (17.5% of equity)
Purpose: improve manufacturing decision-making and operational efficiency
ER (issuer) financials: 2025 revenue KRW 2.16bn, net loss KRW 1.05bn (vs profit prev year), equity KRW 0.67bn
Transaction is internal restructuring; no change in effective control
KOSDAQ Filing Information
Filing: Decision on Acquisition of Stocks and Investment Securities of Other Corporations